Nektar Therapeutics (NasdaqCM:NKTR) Q4 2025 Earnings call March 12, 2026 05:00 PM ET Company ParticipantsCheng Li - Director of Biotech Equity ResearchHoward W. Robin - President and CEOJonathan Zalevsky - Chief Research and Development OfficerMary Tagliaferri - Chief Medical OfficerSandra Gardiner - CFOVivian Wu - Director of Investor RelationsConference Call ParticipantsAndy Hsieh - AnalystArthur He - AnalystJulian Harrison - Managing Director and Biotechnology AnalystMayank Mamtani - AnalystRoger Song - ...